2023
Balboni B., Rinaldi F., Previtali V., Ciamarone A., Girotto S., Cavalli A.
Novel Insights into RAD52’s Structure, Function, and Druggability for Synthetic Lethality and Innovative Anticancer Therapies
Cancers, vol. 15, (no. 6)
2022
Myers S. H., Previtali V., Poppi L., Rinaldi F., Schipani F., Ortega J. O., De Franco F., Veronesi M., Pellicciari R., Roberti M., Girotto S., Di Stefano G., Cavalli A.
Identification and subsequent development of RAD51 inhibitors as potential tools in exploring BRCA2-PARP mediated synthetic lethality
ACS Spring 2022 meeting
Poster
Conference
2022
Previtali V., Myers S. H., Bagnolini G., Poppi L., Rinaldi F., Schipani F., Ortega J. A., De Franco F., Pellicciari R., Girotto S., Oliviero G., Walsh N., Valenti G., Tirelli N., Di Stefano G., Roberti M., Cavalli A.
Insights into the activity of ARN24089, a new RAD51-BRCA2 disruptor that inhibits homologous recombination and achieves synthetic lethality in pancreatic cancer
ACS Spring 2022 meeting
Poster
Conference
2022
Schipani F., Manerba M., Marotta R., Poppi L., Gennari A., Rinaldi F., Armirotti A., Farabegoli F., Roberti M., Di Stefano G., Rocchia W., Girotto S., Tirelli N., Cavalli A.
The Mechanistic Understanding of RAD51 Defibrillation: A Critical Step in BRCA2-Mediated DNA Repair by Homologous Recombination
International Journal of Molecular Sciences, vol. 23, (no. 15)
2022
Rinaldi F., Schipani F., Scietti L., Girotto S., Cavalli A.
Unveiling the molecular mechanism of BRCA2-RAD51 interaction to tackle cancer onset
EMBO Practical Course "Characterization of macromolecular complexes by integrative structural biology"
Poster
Conference
2019
Hutmacher C., Volta L., Rinaldi F., Murer P., Myburgh R., Manz M.G., Neri D.
Development of a novel fully-human anti-CD123 antibody to target acute myeloid leukemia
Leukemia Research, vol. 84